Last updated 2026-07-20
- Raised $10M Series A led by OrbiMed Advisors, Jul 2017
- Raised $4M Secondary led by Avanos Medical, Jul 2020
- Raised Series B led by Avanos, Jun 2022
Total raised
$14.0M
Last: Undisclosed Round 2017-07
Stage
Seed
Founded
2014
Headcount
17
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
FUSMobile develops noninvasive solutions for chronic painful conditions. Their flagship product, Neurolyser XR, is a focused ultrasound treatment platform designed to relieve suffering caused by conditions like chronic lower back (facet joint) pain, knee and hip arthritis, sacroiliitis, and bone metastases. The Neurolyser XR uses high-intensity focused ultrasound guided by X-ray fluoroscopy imaging to heat and destroy sensory nerves, offering a noninvasive alternative to more invasive pain management procedures. The device received De Novo clearance from the US FDA in November 2025 for treating chronic low back pain.
Funding history · 4 rounds · $14.0M total
2022-06
B Round
Undisclosed
★ AvanosAvanos MedicalOrbiMed AdvisorsAtlanta Technology Angels
2020-07
Secondary
$4.0M
★ Avanos MedicalOrbiMed AdvisorsAtlanta Technology Angels
2017-07
A Round
$10.0M
★ OrbiMed AdvisorsOrbiMedAtlanta Technology Angels
2014
Seed
Undisclosed
★ family★ friends★ Ron Aginsky★ Arik Hanannel★ friends & family
Headcount over time
From 4 (2018-11) to 18 (2026-03) · +14 (+350%) · 13 points · source: Finder history + radar grounding
Q&A
- What is FUSMobile's primary focus?
- FUSMobile focuses on advancing noninvasive solutions for chronic painful conditions, aiming to improve patient experience and clinical outcomes while reducing costs for healthcare providers and payers.
- What is FUSMobile's flagship product?
- FUSMobile's flagship product is the Neurolyser, a focused ultrasound treatment platform designed to relieve suffering from conditions such as chronic lower back (facet joint) pain, knee and hip arthritis, sacroiliitis, and bone metastases.
- What is the current development stage of FUSMobile's Neurolyser XR device?
- FUSMobile's Neurolyser XR focused ultrasound device has completed its first-in-human study with positive results and is preparing to enter pivotal clinical trials for North American regulatory approval for facet joint arthritis.
- When was FUSMobile founded?
- FUSMobile was founded in January 2014.
- How many employees does FUSMobile have?
- FUSMobile has 11-50 employees.
- Where is FUSMobile's headquarters located?
- FUSMobile's headquarters is located in Haifa, Israel.
- Which investor participated in FUSMobile's funding round in July 2017?
- OrbiMed participated in FUSMobile's funding round in July 2017.
- What is FUSMobile's primary sector?
- FUSMobile's primary sector is Health Tech & Life Sciences.
Team · 2
Arik Hananel
Founder · CEO and Co-Founder
Ron Aginsky
Founder · President and Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
cancermedical-technologieshealthcare-providershospitalsdoctorsultrasoundmedical-devicesnon-invasiveclinicspain-reliefchronic-paintreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fusmobile.com |
|---|---|
| linkedin.com/company/7603055 |
Identifiers & details
| Legal name | FUSMobile, Inc. |
|---|---|
| Founded | 2014-1 |
| Employees (exact) | 17 |
| Offices | Alpharetta |
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 5 |
|---|
Web history (Wayback)
| Domain | fusmobile.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515740629 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-11-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | אתגר 4 טירת כרמל |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |